Search result for 'assertio holdings'

Zydus Lifesciences has completed its $166.4 million acquisition of US-based Assertio Holdings Inc. Assertio, focused on speciality and oncology care, is now a Zydus subsidiary.

Zydus Lifesciences to acquire Assertio Holdings for USD 166.4 mn, expanding its oncology presence in the US market.